On March 28, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance For Industry On Alzheimer’s Disease: Developing Drugs For The Treatment Of Early Stage Disease; Availability."
The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It is also intended to encourage the submission of questions or comments while the guidance is still in draft form.
Download Presentation Slides: Developing Drugs For The Treatment Of Early Stage Disease (PDF – 481KB)
Archive of Past Webinars: